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Galectin-12, a member of the galectin family of animal lectins,
is preferentially expressed in adipocytes. We recently reported
that this galectin is localized on lipid droplets, specialized
organelles for fat storage. Galectin-12 regulates lipid degrada-
tion (lipolysis) by modulating lipolytic protein kinase A (PKA)
signaling. Mice deficient in galectin-12 exhibit enhanced adi-
pocyte lipolysis, increased mitochondria respiration, reduced
adiposity and ameliorated insulin resistance associated with
weight gain. The results suggest that galectin-12 may be a
useful target for treatment of obesity-related metabolic con-
ditions, such as insulin resistance, metabolic syndrome, and
type 2 diabetes. Most previously described galectins largely
reside in the cytosol, although they can also be induced to
become associated with membrane-containing structures.
Along with an in-depth characterization of galectin-12, this
mini-review comments on this first report of a galectin
normally localized specifically in an organelle that performs
an important intracellular function. Further studies will help
shed light on how this protein regulates cellular homeostasis,
especially energy homeostasis, and provide additional insight
into the intracellular functions of galectins.
Adipocytes, cells that are the primary cellular component of
adipose tissue, play a crucial role in energy homeostasis. They are
specialized to store fatty acids as triglycerides and release free fatty
acids and glycerol according to an organism’s energy status.
Energy intake in excess of energy expenditure, often as a result of
overeating, can lead to lipid overload in adipocytes that causes
obesity and predisposes the animal to other metabolic disorders
such as insulin resistance and type 2 diabetes.1 The protein in
question in our recent paper published in the Proceedings of the
National Academy of Sciences of the United States of America,2
galectin-12, is a member of the galectin family that includes
15 animal lectins so far identified containing one or two
carbohydrate-recognition domains (CRDs) with conserved
consensus sequences and affinity for β-galactosides (Fig. 1A).
The members exhibit considerable diversity in binding preference
that depends on the presentation of β-galactosides in the glycans.3
Unlike many other animal lectins that mainly function from
outside the cells, galectins reside intracellularly, although they
can be secreted, and can function from both inside and outside
the cell in diverse cellular processes (Fig. 1B and reviewed in
refs. 3–5).
Galectin-12, a two-CRD galectin, was cloned a decade ago by
this laboratory.6 Like other galectin genes, galectin-12 gene
(Lgals12) does not encode a signal peptide, suggesting that it
codes for an intracellular protein. The predicted protein exhibits
considerable divergence from consensus sequence among the
galectin family of proteins. Whereas the percentage of sequence
identity among most human galectin CRDs ranges from 20% to
50%, the C-terminal CRD of galectin-12 is less than 20%
identical to most other galectin CRDs and lack several amino
acid residues that are known to be essential for carbohydrate
binding. The gene was found to be predominately expressed
by adipose tissue.7 The protein was previously shown to arrest the
cell cycle at G1 phase when ectopically expressed in some cancer
cells6 and to induce apoptosis in others.7 Kouadjo et al. further
reported that in mice, Lep (encoding the adipocyte hormone
leptin) and Lgals12 were the only two genes exclusively expressed
in adipose tissue.8 The remarkable tissue specificity in galectin-12
expression suggested that this protein might play an important
role in the biology of adipocytes. Indeed, we have now reported
that galectin-12 suppresses lipolysis in adipocytes. Ablation of
this protein in mice leads to increased lipolysis, decreased
adiposity and amelioration of insulin resistance associated with
weight gain.2
Galectin-12 Regulates Lipolysis in Lipid Droplets
Most galectins are cytosolic proteins, although some can be
induced to become associated with membrane structures, such as
lipid rafts, immunological synapses, phagosomes and mitochon-
dria.3 It is therefore a surprise that galectin-12 is not detectable
in the cytosol, but is mainly associated with lipid droplets
under normal conditions.2 Lipid droplets consist of a phospho-
lipid monolayer that surrounds a core of neutral lipids, such as
sterol esters and triglycerides, with a surface that is decorated
with a number of proteins, many of which play functional roles
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in lipid droplet biology.9 Although being ubiquitous organelles
found in most eukaryotic cells, they are especially prominent in
adipocytes. Lipid droplets are the major sites of energy storage
and catabolism, processes highly regulated by hormones and
metabolic signaling pathways.10
Like mRNA for other galectins, galectin-12 mRNA lacks
sequences that encode a classical signal peptide.6 Thus, the protein
is likely to be synthesized in free ribosomes and then directed to
the preexisting lipid droplets. This is similar to the PERILIPIN
family of proteins11,12 and distinct from other non-residential
lipid droplet proteins, such as caveolin and DGAT2, which are
synthesized in the ER and transferred from the endoplasmic
leaflet of the ER membrane to the lipid droplets by inundating
lipids during lipid droplet formation or growth (reviewed in
ref. 9). The lack of association of galectin-12 with other cellular
membranes suggests that the monolayer membrane surface of
lipid droplets is somewhat unique. How galectin-12 distinguishes
between the mono-layer surface of lipid droplets and the bilayer
surfaces of other organelles is not known. One possibility is there
is a dynamic interplay between galectin-12 and lipid droplet-
specific lipids or proteins. The detailed mechanism of how
galectin-12 is localized to lipid droplet is unknown but is likely to
involve hydrophobic regions scattered throughout the galectin-12
protein sequence.2
Since the discovery of the regulation of lipolysis by the lipid
droplet protein PERILIPIN 1 (PLIN1),13-15 it is clear that the
metabolic function of these organelles is in part mediated by their
associated proteins. PLIN1 acts both as a barrier that limits the
access of lipases to the core of triglycerides and as a regulatory
protein that controls lipase activation and translocation.16
Ablation of PLIN1 exposes the lipid droplet core to the actions
of lipases and results in maximal lipolysis under basal conditions.
Incubation with catecholamines does not produce further
stimulation of lipolysis in PLIN1-deficient adipocyte.14,15 In
contrast, ablation of galectin-12 leads to enhancement of both
basal and catecholamine-stimulated lipolysis.2 The results suggest
that unlike PLIN1, galectin-12 mainly acts as a regulator of pro-
lipolytic signaling and not as a major structural protein that
shields the lipid droplet core from the actions of lipases. This is
consistent with the finding that galectin-12 is preferentially
localized to certain surface domains of large lipid droplets, which
are known to be less sensitive to lipolytic stimulation than those
smaller droplets.17
Protein kinase A (PKA) signaling is a major regulator of
lipolysis. PKA signaling is known to be compartmentalized signal
emanated by a specific stimulus is directed to particular cellular
sites where a functionally-related subset of PKA substrates are
phosphorylated and activated (or inactivated).18,19 Galectin-12
may be localized to such domains of lipolytic PKA signaling and
contribute to the compartmentalization of PKA signaling by
acting as a scaffold protein that interacts with specific signaling
molecules, as proposed by Baum.20 This is analogous to another
galectin, galectin-3, which has been shown to function as a
scaffold protein in the formation of nanoclusters with K-ras on the
Figure 1. Galectin structure and function. (A) Galectin subtypes and structural features. Prototypical galectins are composed of a single galectin CRD.
The chimeric type of galectin, galectin-3, consists of a N-terminal non-lectin domain in addition to a C-terminal galectin CRD. Tandem repeat type
of galectins contains 2 CRDs in tandem connected by a linker sequence. (B) Galectins are synthesized in the cytosol but can also be secreted through
poorly-defined mechanisms. Functioning from both outside and inside of the cell, galectins are involved in diverse cellular processes including vesicle
trafficking of glycoproteins, chemotaxis, proliferation, pre-RNA splicing, and apoptosis. Extracellular galectins are likely to function by binding to cell
surface glycans, while intracellular effectors that mediate galectin function are largely unknown.
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plasma membrane.21 It thus can be predicted that galectin-12
ablation preferentially affects PKA signaling that targets lipolysis,
while other PKA-activated cellular processes, such as activation of
CREB-mediated transcription in the nucleus, are not affected.
This remains to be confirmed experimentally.
Galectin-12-deficient adipocytes also exhibit enhanced mito-
chondrial respiration.2 Although this can be explained by
increased availability of fuels (fatty acids) to mitochondria as a
result of enhanced lipolysis in these cells, a more direct role for
galectin-12 in mitochondrial activity cannot be excluded. Some
mitochondria are located in close association with lipid droplets in
adipocytes and there could be an exchange of surface materials
between the two organelles. It will be interesting to determine
whether galectin-12 exists in this subset of mitochondria.
Galectin-12 at the interface of the two organelles could also
regulate local lipid fluxes of fatty acids from the lipid droplets
to mitochondria for oxidation. In any rate, increased fatty
acid oxidation and mitochondrial respiration in the face of
enhanced lipolysis may contribute to greater energy expenditure
in Lgals122/2 animals. A combination of these factors reduces
adiposity and in the meantime prevents a rise of fatty acid levels in
the circulation and limits lipid deposition in insulin sensitive
tissues, resulting in improved insulin sensitivity.2 It should be
noted, however, that normal amount of adipose tissue is essential
for the maintenance of energy homeostasis,22-25 and genetic
manipulations that reduce the capacity of fat storage in this tissue
often lead to increased fatty acid levels in the circulation, ectopic
deposition of lipids in muscle and liver, and impaired insulin
sensitivity.15,26-28
Roles of Galectin-12 in Other Cells
While galectin-12 is predominately produced in adipocytes in
mice, it is also expressed in human leukocytes, especially myeloid
cells.6 Species differences in the temporal and spatial expression of
some genes are not uncommon. For example, the adipokine
resistin that exacerbates adipose tissue inflammation and insulin
resistance is produced exclusively by adipose tissue in mice, but
mainly expressed in macrophages in humans.29,30 Major adipo-
genic transcription factors such as the C/EBP and PPAR families
of transcription factors also play critical roles in myeloid
differentiation and function.31-34 Thus, adipocytes and cells of
myeloid origin may be much more similar than previously
considered. Indeed, it has recently been reported that white
adipocytes can be generated from the myeloid lineage via
mesenchymal intermediates.35
Leukocytes actively accumulate lipid droplets in infectious and
other inflammatory conditions.36,37 In addition to its well-known
role as a site for lipid storage, lipid droplets also house a variety of
signaling molecules that regulate not only energy metabolism,
but also many other cellular processes. A key role for this organelle
as an energy store and a cytoplasmic domain that organizes
intracellular signaling in immune responses is coming to light.37,38
Whether galectin-12 is also localized to lipid droplets in
leukocytes and its precise role in the immune response remain
to be determined.
Roles of the Carbohydrate-Recognition Domains
in Intracellular Galectin-12 Function
While galectins are able to exert various activities in vitro by
engaging cell surface glycans, as demonstrated by addition of
recombinant proteins to cell lines or primary cells from humans or
animals, it has become increasingly clear they can regulate cellular
responses by functioning intracellularly.3 Our findings of the role
of galectin-12 in regulation of lipolysis and its localization to lipid
droplets provide another example of intracellular functions.
At this time, most studies of galectins have considered the
carbohydrate-binding regions as the functional sites that elicit direct
cellular responses through binding to glycans. However, it is also
possible for these regions to serve as regulatory sites whose occupancy
regulates (instead of mediates) galectin function. It has been shown
that carbohydrate binding to the C-terminal CRD of galectin-3
affects its N-terminal domain-mediated self-association.39 Although
such regulatory molecules for galectin-12 remain to be identified,
they are likely to be intracellular metabolic intermediates that may or
may not be carbohydrates in structure. Binding of these molecules to
the presumably carbohydrate-binding sites of galectin-12 may affect
its interaction with as yet unknown effector molecules that mediate
its metabolic function. A major theme in metabolic regulation is that
alterations of nutritional status result in fluctuations in the levels of
metabolic intermediates, which in turn allosterically regulate
enzymes of their respective metabolic pathways to achieve metabolic
homeostasis. We now propose that the metabolic function of
galectin-12 may be similarly regulated to help maintain energy
homeostasis. It is to be noted also that galectin-12 CRDs, especially
the C-terminal one, display considerable divergence from other
galectin CRDs.6 Although the protein retains some lactose-binding
activity (likely contributed by its N-terminal CRD),6,7 it is possible
that the C-terminal domain, which lacks several of the key amino
acid residues known to be crucial for β-galactoside binding, has
evolved to preferentially bind ligands other than carbohydrates.
Concluding Remarks
An important role for galectin-12 in the regulation of lipolysis and
whole-body energy metabolism has thus been identified (Fig. 2).
Yet many crucial questions remain to be answered. What are the
functions of galectin-12 in other cell types, especially in humans
where its expression is not as restricted to adipocytes as it is in
mice? Are different galectin-12 functions mediated by distinct or
same factors? What is the relevance of the carbohydrate-binding
sites for such an intracellular lectin? How are the different
functions of galectin-12 regulated? These and other unanswered
questions remind us that we are just beginning to unravel the
many mysteries of this intriguing protein. Further studies of
localization and identification of cellular components that interact
with galectin-12 will help shed light on how this protein regulates
cellular homeostasis, especially energy homeostasis, as well as
providing additional insight into the intriguing family of galectins.
Lastly, galectin-12 may be a useful target for the management of
obesity-related metabolic conditions, such as insulin resistance,
metabolic syndrome and type-2 diabetes.
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Figure 2. Role of galectin-12 in the regulation of lipolysis in adipocytes by protein kinase A (PKA) signaling. (A) Lipolysis in a wildtype (Lgals12+/+)
adipocyte. PKA is activated by cyclic AMP (cAMP) to set off a signaling cascade that results in the sequential hydrolysis of triglyceride (TG) in the lipid
droplet (yellow ball) to free fatty acids (FFAs) and glycerol. In this cell, the lipid droplet protein galectin-12 limits cAMP levels to downregulate PKA
activation, most likely by acting on specific phosphodiesterases that degrade cAMP. (B) Ablation of galectin-12 in adipocytes results in elevated
concentrations of cAMP, enhanced lipolytic PKA signaling, and therefore augmentation of lipolysis.
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